Literature DB >> 11975090

[The Multiple Sclerosis Documentation System MSDS. Discussion of a documentation standard for multiple sclerosis].

M Pette1, M Eulitz.   

Abstract

The MSDS (multiple sclerosis documentation system) has been developed at the Department of Neurology, Technical University of Dresden, Germany, during the last 4 years. The first version of this database application has been in use since October 2000. The MSDS manages information on MS patients, their treating physicians, patient history (symptoms, other diseases, biographical history, family history, habits, medication), clinical signs, results of laboratory examinations (blood chemistry, autoantibodies, borrelia serology, evoked potentials, cranial and spinal cord magnetic resonance imaging), clinical scores relevant for MS, and biosamples. In principle, MSDS allows online data input and semiautomatically generates reports to all general practitioners and neurologists treating the respective patient. Patient information sheets and internal treatment guidelines are part of the system. During a 3-month evaluation, the first version of MSDS was tested at eight university multiple sclerosis ambulatory care units and one general neurology hospital. The overall judgement was favorable. Suggestions for changes and improvements, as well as practical experiences, were considered when developing MSDS 2.0, which will be available by the end of 2001.

Entities:  

Mesh:

Year:  2002        PMID: 11975090     DOI: 10.1007/s00115-001-1220-0

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  6 in total

1.  [MS registry in Germany--design and first results of the pilot phase].

Authors:  P Flachenecker; U K Zettl; U Götze; J Haas; S Schimrigk; W Elias; M Pette; M Eulitz; M Hennig; J Bertram; R Hollweck; A Neiss; M Daumer; D Pitschnau-Michel; P Rieckmann
Journal:  Nervenarzt       Date:  2005-08       Impact factor: 1.214

Review 2.  [Multiple sclerosis management system 3D. Moving from documentation towards management of patients].

Authors:  T Schultheiss; R Kempcke; F Kratzsch; M Eulitz; M Pette; H Reichmann; T Ziemssen
Journal:  Nervenarzt       Date:  2012-04       Impact factor: 1.214

Review 3.  Multiple sclerosis documentation system (MSDS): moving from documentation to management of MS patients.

Authors:  Tjalf Ziemssen; Raimar Kempcke; Marco Eulitz; Lars Großmann; Alexander Suhrbier; Katja Thomas; Thorsten Schultheiss
Journal:  J Neural Transm (Vienna)       Date:  2013-06-01       Impact factor: 3.575

4.  Rationale, design, and methods of a non-interventional study to establish safety, effectiveness, quality of life, cognition, health-related and work capacity data on Alemtuzumab in multiple sclerosis patients in Germany (TREAT-MS).

Authors:  Tjalf Ziemssen; Ulrich Engelmann; Sigbert Jahn; Alexandra Leptich; Raimar Kern; Lina Hassoun; Katja Thomas
Journal:  BMC Neurol       Date:  2016-07-19       Impact factor: 2.474

5.  Data Collection in Multiple Sclerosis: The MSDS Approach.

Authors:  Tjalf Ziemssen; Raimar Kern; Isabel Voigt; Rocco Haase
Journal:  Front Neurol       Date:  2020-06-16       Impact factor: 4.003

6.  Designing an Electronic Patient Management System for Multiple Sclerosis: Building a Next Generation Multiple Sclerosis Documentation System.

Authors:  Raimar Kern; Rocco Haase; Judith Christina Eisele; Katja Thomas; Tjalf Ziemssen
Journal:  Interact J Med Res       Date:  2016-01-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.